GROUP ONE TRADING, L.P. - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 51 filers reported holding APREA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$14,165
-29.2%
44,003
+41.9%
0.00%
Q3 2022$20,000
-16.7%
31,003
-5.5%
0.00%
Q2 2022$24,000
-75.8%
32,803
-38.2%
0.00%
Q1 2022$99,000
-50.5%
53,104
-24.0%
0.00%
Q4 2021$200,000
-46.2%
69,840
-4.1%
0.00%
Q3 2021$372,000
+42.5%
72,841
+36.3%
0.00%
Q2 2021$261,000
+5120.0%
53,445
+5244.5%
0.00%
Q1 2021$5,0001,0000.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 1,377,654$6,778,0002.28%
Versant Venture Management, LLC 1,426,328$7,018,0000.73%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$206,0000.38%
Redmile Group, LLC 1,268,718$6,242,0000.08%
Gyon Technologies Capital Management, LP 41,801$206,0000.07%
SECTORAL ASSET MANAGEMENT INC 163,681$805,0000.06%
Palo Alto Investors LP 128,770$634,0000.03%
Walleye Capital LLC 100,800$496,0000.03%
Virtus ETF Advisers LLC 10,261$50,0000.02%
Candriam S.C.A. 362,346$1,783,0000.01%
View complete list of APREA THERAPEUTICS INC shareholders